RD3-0028

• Description:

  RD3-0028 is a potent and selective inhibitor of RSV replication with an EC50 of 4.5 μM.

• UNSPSC:

  12352005

• Hazard Statement:

  H302-H315-H319-H335

• Target:

  RSV

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-anti-virus

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/RD3-0028.html

• Solubility:

  10 mM in DMSO

• Smiles:

  C12=CC=CC=C1CSSC2

• Molecular Formula:

  C8H8S2

• Molecular Weight:

  168.28

• Precautions:

  P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501

• References & Citations:

  [1]Watanabe W, et al. Novel anti-respiratory syncytial (RS) viral compounds: benzodithiin derivatives. Biochem Biophys Res Commun. 1998 Aug 28;249 (3) :922-6.|[2]Sudo K, et al. Efficacy of RD3-0028 aerosol treatment against respiratory syncytial virus infection in immunosuppressed mice. Antimicrob Agents Chemother. 1999 Apr;43 (4) :752-7.|[3]Sudo K, et al. Pharmacokinetics of a benzodithiin (RD3-0028) following aerosol treatment in rat.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [3886-39-3]